Form 4: Disc Medicine Director William White Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director William Richard White exercised stock options and sold shares of Disc Medicine, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 1, 2024, William Richard White, a director of Disc Medicine, Inc. (IRON), exercised stock options to acquire 201 shares of common stock at a price of $9.86 per share.
• Simultaneously, White sold 201 shares at $9.86, 162 shares at a weighted average price of $28.5154 (ranging from $27.79 to $28.78), and 39 shares at a weighted average price of $29.1147 (ranging from $28.79 to $29.682).
• These transactions were executed under a Rule 10b5-1 trading plan adopted on December 13, 2023.
• Following these transactions, White still beneficially owns 3,211 derivative securities (stock options) and no shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. There's no indication of positive or negative sentiment from the filing itself.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (directors, officers, or those holding more than 10% of the company's shares) trade in their company's stock. These filings provide transparency into insider activity and are closely watched by investors.

Comparison to Industry Standards

• Insider transactions are common, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on non-public information.
• The details provided, such as the price ranges for the sales, are consistent with SEC requirements for transparency.
• Comparable companies in the biotechnology sector, such as Agios Pharmaceuticals or Global Blood Therapeutics (prior to its acquisition by Pfizer), would have similar insider trading patterns and reporting requirements.

Stakeholder Impact

• The transactions may have a minor impact on shareholders as they reflect insider selling, but the existence of a 10b5-1 plan mitigates concerns about opportunistic trading.

Key Dates